|Pain assessment: global use of the Brief Pain Inventory.|
CS Cleeland, KM Ryan
Annals, academy of medicine, Singapore, 1994
|Pain and its treatment in outpatients with metastatic cancer|
CS Cleeland, R Gonin, AK Hatfield, JH Edmonson, RH Blum, JA Stewart, ...
New England Journal of Medicine 330 (9), 592-596, 1994
|Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations|
RH Dworkin, DC Turk, KW Wyrwich, D Beaton, CS Cleeland, JT Farrar, ...
The Journal of Pain 9 (2), 105-121, 2008
|The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory|
TR Mendoza, XS Wang, CS Cleeland, M Morrissey, BA Johnson, ...
Cancer 85 (5), 1186-1196, 1999
|Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases|
RL Daut, CS Cleeland, RC Flanery
Pain 17 (2), 197-210, 1983
|When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function|
RC Serlin, TR Mendoza, Y Nakamura, KR Edwards, CS Cleeland
Pain 61 (2), 277-284, 1995
|Assessing symptom distress in cancer patients: the MD Anderson Symptom Inventory|
CS Cleeland, TR Mendoza, XS Wang, C Chou, MT Harle, M Morrissey, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2000
|Core outcome domains for chronic pain clinical trials: IMMPACT recommendations|
DC Turk, RH Dworkin, RR Allen, N Bellamy, N Brandenburg, DB Carr, ...
Pain 106 (3), 337-345, 2003
|Physician attitudes and practice in cancer pain management: a survey from the Eastern Cooperative Oncology Group|
JH Von Roenn, CS Cleeland, R Gonin, AK Hatfield, KJ Pandya
Annals of Internal medicine 119 (2), 121-126, 1993
|Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain|
S Keller, CM Bann, SL Dodd, J Schein, TR Mendoza, CS Cleeland
The Clinical journal of pain 20 (5), 309-318, 2004
|Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases|
WF Hartsell, CB Scott, DW Bruner, CW Scarantino, RA Ivker, M Roach III, ...
Journal of the National Cancer Institute 97 (11), 798-804, 2005
|Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing|
JL Gabrilove, CS Cleeland, RB Livingston, B Sarokhan, E Winer, ...
Journal of Clinical Oncology 19 (11), 2875-2882, 2001
|The prevalence and severity of pain in cancer|
RL Daut, CS Cleeland
Cancer 50 (9), 1913-1918, 1982
|Quality improvement guidelines for the treatment of acute pain and cancer pain|
MB Max, M Donovan, CA Miaskowski, SE Ward, D Gordon, M Bookbinder, ...
Jama 274 (23), 1874-1880, 1995
|Measurement of pain by subjective report|
Advances in pain research and therapy 12, 391-403, 1989
|Pain and treatment of pain in minority patients with cancer: the Eastern Cooperative Oncology Group Minority Outpatient Pain Study|
CS Cleeland, R Gonin, L Baez, P Loehrer, KJ Pandya
Annals of internal medicine 127 (9), 813-816, 1997
|Management of cancer pain|
Clinical practice guideline, 1994
|NCCN practice guidelines for cancer-related fatigue.|
V Mock, A Atkinson, A Barsevick, D Cella, B Cimprich, C Cleeland, ...
Oncology (Williston Park, NY) 14 (11A), 151-161, 2000
|Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine‐immunologic model of cancer symptoms|
CS Cleeland, GJ Bennett, R Dantzer, PM Dougherty, AJ Dunn, CA Meyers, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2003
|Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy|
J Crawford, D Cella, CS Cleeland, PY Cremieux, GD Demetri, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2002